These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31924363)

  • 1. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
    Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
    Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
    Stokes SM; Massarweh NN; Stringham JR; Varghese TK
    Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
    Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
    Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
    Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
    Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
    Odell DD; Feinglass J; Engelhardt K; Papastefan S; Meyerson SL; Bharat A; DeCamp MM; Bilimoria KY
    J Thorac Cardiovasc Surg; 2019 Mar; 157(3):1219-1235. PubMed ID: 31343410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer.
    Wakeam E; Giuliani M; Leighl NB; Finlayson SRG; Varghese TK; Darling GE
    Ann Thorac Surg; 2017 May; 103(5):1647-1653. PubMed ID: 28267977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
    Collins ML; Mack SJ; Whitehorn GL; Till BM; Grenda TR; Evans NR; Gordon SW; Okusanya OT
    Ann Thorac Surg; 2024 Mar; 117(3):568-575. PubMed ID: 37995842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
    Yorio JT; Yan J; Xie Y; Gerber DE
    Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.
    Speicher PJ; Fitch ZW; Gulack BC; Yang CJ; Tong BC; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
    Ann Thorac Surg; 2016 Sep; 102(3):884-894. PubMed ID: 27476819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States.
    Fan Q; Hussaini SMQ; Barrow LCJ; Feliciano JL; Pollack CE; Yabroff KR; Nogueira L
    Cancer Med; 2024 Feb; 13(3):e6921. PubMed ID: 38205942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
    Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
    Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
    Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
    Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
    J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.